SSLRXSalarius Pharmaceuticals Inc

Salarius Pharmaceuticals Inc

SLRX

1D · 1W · 1M · 3M · YTD · 1Y · 5Y · AllLive SLRX chart

  • Mkt cap

    $4.92M

  • EV/Sales

    N/A

  • P/E ratio

    N/A

  • Revenue (qtr ended 2026-06-30)

    $227,629

  • EPS (H1 2026)

    $-8.64

  • Gross Margin (qtr ended 2026-06-30)

    N/A

  • Profit Margin (qtr ended 2026-06-30)

    -1042.84%

  • Beta

    N/A

  • Div yield

    N/A

  • Sector

    Healthcare

No recent filings in cache.

Live SLRX terminalLician Pro · $19.99/mo or $149/yrPeer financials on ProAPI free 100/dayCompare AAPL vs MSFT

SLRX — Salarius Pharmaceuticals Inc · $4.9M cap

SLRX Key Statistics

  • Market Cap: $4.9M
  • P/B Ratio: 1.13

Salarius Pharmaceuticals Inc latest statements (FY2025)

Latest cached year on this hub. Full SLRX income, balance, and cash tables.

  • Net Income-$12.5M
  • Total Assets$11.1M
  • Free Cash Flow-$5.4M

SLRX FAQ

What industry is SLRX in?

Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company in the Healthcare sector.

What are SLRX's latest revenue and net income?

Latest cached Salarius Pharmaceuticals Inc (SLRX) revenue for Jun 30, 2026 was $227.6K. Net income was -$2.4M. Statements: https://lician.com/financials/slrx

What is SLRX's market cap?

Salarius Pharmaceuticals Inc (SLRX) market capitalization is $4.9M on the latest cached snapshot.

Live SLRX terminal loads when you scroll near this section.